These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20141378)

  • 1. The impact of delaying the initiation of appropriate antifungal treatment for Candida bloodstream infection.
    Kludze-Forson M; Eschenauer GA; Kubin CJ; Della-Latta P; Lam SW
    Med Mycol; 2010 Mar; 48(2):436-9. PubMed ID: 20141378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
    Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
    J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.
    Garey KW; Rege M; Pai MP; Mingo DE; Suda KJ; Turpin RS; Bearden DT
    Clin Infect Dis; 2006 Jul; 43(1):25-31. PubMed ID: 16758414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality.
    Morrell M; Fraser VJ; Kollef MH
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3640-5. PubMed ID: 16127033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes.
    Shah DN; Yau R; Weston J; Lasco TM; Salazar M; Palmer HR; Garey KW
    J Antimicrob Chemother; 2011 Sep; 66(9):2146-51. PubMed ID: 21700622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial.
    DiNubile MJ; Lupinacci RJ; Strohmaier KM; Sable CA; Kartsonis NA
    J Crit Care; 2007 Sep; 22(3):237-44. PubMed ID: 17869975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes.
    Grim SA; Berger K; Teng C; Gupta S; Layden JE; Janda WM; Clark NM
    J Antimicrob Chemother; 2012 Mar; 67(3):707-14. PubMed ID: 22184469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of caspofungin and amphotericin B for invasive candidiasis.
    Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
    N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the initial dose of micafungin and its efficacy in patients with candidemia.
    Ota Y; Tatsuno K; Okugawa S; Yanagimoto S; Kitazawa T; Fukushima A; Tsukada K; Koike K
    J Infect Chemother; 2007 Aug; 13(4):208-12. PubMed ID: 17721682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
    Klevay MJ; Horn DL; Neofytos D; Pfaller MA; Diekema DJ;
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New options for treatment of candidaemia in critically ill patients.
    Ruhnke M; Hartwig K; Kofla G
    Clin Microbiol Infect; 2008 May; 14 Suppl 4():46-54. PubMed ID: 18430129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant.
    Natale F; Castronovo A; Regoli D; De Curtis M; Manzoni P
    Pediatr Infect Dis J; 2009 May; 28(5):452. PubMed ID: 19295457
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment-related risk factors for hospital mortality in Candida bloodstream infections.
    Labelle AJ; Micek ST; Roubinian N; Kollef MH
    Crit Care Med; 2008 Nov; 36(11):2967-72. PubMed ID: 18824910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of breakthrough Candida bloodstream isolates correlates with daily and cumulative doses of fluconazole.
    Clancy CJ; Staley B; Nguyen MH
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3496-8. PubMed ID: 17005842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory neonatal candidemia and high-dose micafungin pharmacotherapy.
    Natarajan G; Lulic-Botica M; Aranda JV
    J Perinatol; 2009 Nov; 29(11):738-43. PubMed ID: 19776753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
    Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
    J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
    Pappas PG; Rotstein CM; Betts RF; Nucci M; Talwar D; De Waele JJ; Vazquez JA; Dupont BF; Horn DL; Ostrosky-Zeichner L; Reboli AC; Suh B; Digumarti R; Wu C; Kovanda LL; Arnold LJ; Buell DN
    Clin Infect Dis; 2007 Oct; 45(7):883-93. PubMed ID: 17806055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.